Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0079744
Disease: Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
0.300 Biomarker disease CTD_human Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphoma. 22474449 2012
CUI: C0200638
Disease: Eosinophil count procedure
Eosinophil count procedure
0.100 GeneticVariation phenotype GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
CUI: C0200635
Disease: Lymphocyte Count measurement
Lymphocyte Count measurement
0.100 GeneticVariation phenotype GWASDB The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma candidate genes. 22286170 2012
CUI: C0410005
Disease: Nodular fasciitis
Nodular fasciitis
0.010 Biomarker disease BEFREE Indeed, it revealed COL1A1 and SEC31A as novel fusion partners for USP6 in nodular fasciitis. 30139549 2018
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
0.010 AlteredExpression disease BEFREE This is the first report of SEC31A-ALK fusion transcript in clinical NSCLC, which could be a novel diagnostic and therapeutic target for patients with NSCLC. 25715771 2016
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
Adenocarcinoma of lung (disorder)
0.010 Biomarker disease BEFREE SEC31A-ALK Fusion Gene in Lung Adenocarcinoma. 25715771 2016
CUI: C0025286
Disease: Meningioma
Meningioma
0.010 Biomarker disease BEFREE Combination of over expression of TCEA1, UBE2E1, XRCC5, IFIT1, IFIT-3, MCM2, and MCM7 and under expression of CDC25A, SEC31A, and CDK6 can serve as diagnostic biomarker panel for meningiomas. 24724603 2014
Precursor T-cell lymphoblastic lymphoma
0.010 Biomarker disease BEFREE In vivo, SEC31A-JAK2 was found to induce a T-lymphoblastic lymphoma or myeloid phenotype in a murine bone marrow transplantation model. 21325169 2011
CUI: C1332213
Disease: Adult T Lymphoblastic Lymphoma
Adult T Lymphoblastic Lymphoma
0.010 Biomarker disease BEFREE In vivo, SEC31A-JAK2 was found to induce a T-lymphoblastic lymphoma or myeloid phenotype in a murine bone marrow transplantation model. 21325169 2011
CUI: C1332998
Disease: Childhood T Lymphoblastic Lymphoma
Childhood T Lymphoblastic Lymphoma
0.010 Biomarker disease BEFREE In vivo, SEC31A-JAK2 was found to induce a T-lymphoblastic lymphoma or myeloid phenotype in a murine bone marrow transplantation model. 21325169 2011
CUI: C1333064
Disease: Classical Hodgkin's Lymphoma
Classical Hodgkin's Lymphoma
0.010 Biomarker disease BEFREE The finding that SEC31A-JAK2 responds to JAK inhibitors indicates that patients with cHL and JAK2 rearrangements may benefit from targeted therapies. 21325169 2011
CUI: C2347747
Disease: Adult Classical Hodgkin Lymphoma
Adult Classical Hodgkin Lymphoma
0.010 Biomarker disease BEFREE The finding that SEC31A-JAK2 responds to JAK inhibitors indicates that patients with cHL and JAK2 rearrangements may benefit from targeted therapies. 21325169 2011
CUI: C0024299
Disease: Lymphoma
Lymphoma
0.010 GeneticVariation group LHGDN Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. 16161041 2006
CUI: C0334121
Disease: Inflammatory Myofibroblastic Tumor
Inflammatory Myofibroblastic Tumor
0.010 Biomarker disease BEFREE Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor. 16161041 2006